primary hyperparathyroidism phpt medical condition parathyroid gland benign tumor within produce excess amounts parathyroid hormone pth symptoms condition relate resulting elevated serum calcium hypercalcemia cause digestive symptoms kidney stones psychiatric abnormalities bone disease diagnosis initially made blood tests elevated level calcium together raised inappropriately high level parathyroid hormone typically found identify source excessive hormone secretion medical imaging may performed parathyroidectomy surgical removal one parathyroid glands may required control symptoms signs symptoms primary hyperparathyroidism hypercalcemia classically summarized stones bones abdominal groans thrones psychiatric left ventricular hypertrophy may also signs include proximal muscle weakness itching band keratopathy eyescitation needed subjected formal research symptoms depression pain gastric dysfunction seem correlate mild cases common cause primary hyperparathyroidism sporadic single parathyroid resulting clonal mutation less common parathyroid parathyroid carcinoma malignant tumor adenomas one gland together hyperparathyroidism also feature several familial endocrine disorders multiple endocrine neoplasia type type men type men type familial hyperparathyroidismcitation needed genetic associations include cases disease idiopathic thought involve inactivation tumor suppressor genes menin gene involve gain function mutations ret protooncogene men needed recently demonstrated liquidators chernobyl power plant faced substantial risk primary hyperparathyroidism possibly caused radioactive strontium diagnosis primary hyperparathyroidism made blood testscitation needed serum calcium levels usually elevated parathyroid hormone level abnormally high compared expected low level response high calcium relatively elevated parathyroid hormone estimated sensitivity specificity approximately primary powerful variant comparing balance calcium parathyroid hormone perform calcium infusion infusion parathyroid hormone level cutoff ngl sensitivity specificity detecting primary hyperparathyroidism confidence interval urinary camp occasionally measured generally elevated due activation gs proteins pth binds biochemical confirmation primary hyperparathyroidism following investigations localize culprit lesion primary hyperparathyroidism commonly due solitary parathyroid adenoma less commonly may due double parathyroid adenomas parathyroid hyperplasia sestamibi scan head neck upper thorax commonly used test localizing parathyroid adenomas sensitivity specificity sensitivity falls case doublemultiple parathyroid adenomas case parathyroid hyperplasia ultrasonography also useful test localizing suspicious parathyroid lesionscitation needed normocalcemic phpt first recognized international panel definition patients normal serum calcium though usually upper range typically found elevated pth workup osteoporosis order diagnose normocalcemic phpt ionized calcium levels normal secondary causes secondary hyperparathyroidism vitamin deficiency chronic kidney disease ruled treatment usually surgical removal glands containing adenomas medication may also requiredcitation needed surgical removal one parathyroid glands known parathyroidectomy operation first performed symptoms disease listed indications surgery surgery reduces cause mortality well resolving symptoms however cardiovascular mortality significantly nih workshop asymptomatic primary hyperparathyroidism developed criteria surgical intervention criteria revised third international workshop management asymptomatic primary hyperparathyroidism criteria chosen basis clinical experience observational clinical trial data patients likely endorgan effects primary hyperparathyroidism nephrolithiasis skeletal involvement disease progression surgery deferred benefit surgery panel emphasized need parathyroidectomy performed surgeons highly experienced skilled operation third international workshop guidelines concluded surgery indicated asymptomatic patients meet one following conditionscitation needed operative intervention delayed patients years age asymptomatic minimally symptomatic serum calcium concentrations mgdl mmoll upper limit normal patients medically unfit surgerycitation needed recently three randomized controlled trials studied role surgery patients asymptomatic hyperparathyroidism largest study reported surgery resulted increase bone mass improvement quality life one two years among patients following two trials reported improvements bone density improvement quality life medications used surgery indicated poor surgical calcimimetics used reduce amount parathyroid hormone released parathyroid glands subsequent hypercalcemia medications used phpt includes treatments osteoporosis estrogen replacement therapy bisphosphonates denosumab treatment hypercalciuria reduce risk kidney primary hyperparathyroidism affects approximately per people new cases per people per year united prevalence primary hyperparathyroidism estimated general population high postmenopausal almost exactly three times common women mencitation needed primary hyperparathyroidism associated increased allcause contrast primary hyperparathyroidism adults primary hyperparathyroidism children considered rare endocrinopathy pediatric primary hyperparathyroidism distinguished severe manifestations contrast less intense manifestations adult primary hyperparathyroidism multiple endocrine neoplasia likely associated childhood adolescent primary hyperparathyroidism fundamental skeletal radiologic manifestation include diffuse osteopenia pathologic fractures coexistence resorption sclerosis numerous sites skeletal lesions specifically bilateral symmetric multifocal exhibiting different types bone resorption pathologic fractures femoral neck spine potentially initiate serious complications pediatric primary hyperparathyroidism frequently associated pathologic fractures misdiagnosed osteogenesis imperfecta pediatric patients primary hyperparathyroidism best remedied parathyroidectomy early diagnosis pediatric primary hyperparathyroidism allimportant minimize disease complications start timely relevant future developments calcimimetic agents eg cinacalcet activate parathyroid calciumsensing receptor may offer good alternative surgerycitation needed httpsenwikipediaorgwikiprimaryhyperparathyroidism